Global Plant-based Biologics Market Overview:
Plant-based biologics can be defined as a Schedule D (biologic) drug produced using plant molecular farming. It is the outcome of an advanced application of biotechnology on plants that enables them to produce therapeutic protein. Plant-based biologics is considered as a perfect substitute for traditional techniques that uses microbial fermentation or animal cell culture. This technology is well-equipped in providing patients greater and immediate access to treatments and is foreseen to expand its uses in the upcoming years. Some of the key players profiled in the study are Fraunhofer IME (Germany), PlantForm (Canada), Mapp Biopharmaceautical (United States), Kentucky BioProcessing, Inc. (United States), Icon Genetics GmbH (Germany), Medicago, Inc. (Canada), iBio Inc. (United States), Greenovation Biotech GmbH (Germany) and Ventria Bioscience Inc. (United States).
On the basis of geography, the market of Plant-based Biologics has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Source , the sub-segment i.e. Carrot will boost the Plant-based Biologics market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Plant Parts, the sub-segment i.e. Leaf-based will boost the Plant-based Biologics market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Increase in the Number of Chronic Diseases and Consequent Demand for Biologics
- Advancements in Plant Biotechnology Area
- Technological innovations related to the Production of Plant-Derived Biologics Drugs
- Low Cost of Manufacturing for the Production of Plant-based Biologics
- Used as Biocontrol Agents of Foodborne Pathogens
- Strict Government Regulation
In April 2020 iBio, Inc., a biologics contract manufacturing organization and biotechnology company, provided an update on its COVID-19 vaccine manufacturing capacity and announced that it has joined the National Institute for Innovation in Manufacturing Biopharmaceuticals (“NIIMBL”), one of 14 institutes in the Manufacturing USA Network.
Target Audience:Research and Development Institutes, Potential Investors, Regulatory Bodies, National Laboratories, Industry Associations and Others
Major Objectives Focused through this Study To define, describe, and forecast the Global Plant-based Biologics market on the basis of product  , application , key regions and end user
To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
To provide market size for various segments of the Plant-based Biologics market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
To strategically profile the key players and analyzing their market shares and core competencies in the Plant-based Biologics industry
To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market
Available Customization: Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are .
** Confirmation on availability of data would be informed prior purchase
While framing the research framework, major and emerging players operating in the Plant-based Biologics market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Dow Jones (Factiva), along with primary respondents. The complete methodology includes the study of the annual and financial reports of the key market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) related to the market.